[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels
about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTApplication of cross-species PET imaging to assess neurotransmitter release in brainNeuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivityAlterations in cortical network oscillations and parvalbumin neurons in schizophrenia.The relationship between glucose metabolism, resting-state fMRI BOLD signal, and GABAA-binding potential: a preliminary study in healthy subjects and those with temporal lobe epilepsy.How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and WithdrawalElevating endogenous GABA levels with GAT-1 blockade modulates evoked but not induced responses in human visual cortex.Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh ReceptorsIn vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor.PET radioligands targeting the brain GABAA /benzodiazepine receptor complex.External awareness and GABA--a multimodal imaging study combining fMRI and [18F]flumazenil-PET.News and views on in-vivo imaging of neurotransmission using PET and MRI.Functional Recovery After Ischemic Stroke Is Associated With Reduced GABAergic Inhibition in the Cerebral Cortex: A GABA PET Study.Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070.
P2860
Q26749755-DBEC9FD1-0B85-4440-83AC-2B8E22EA394EQ26865012-599AC5A6-E3FC-4E66-A1A1-133265DDAEE6Q31031649-9734A130-165D-48ED-B9B1-477B58687607Q34471254-B07E45D3-0326-46A5-B898-2DE457FF438FQ35572846-AA7371A3-2176-4B8A-BE1B-C4CFFAE899ABQ36460012-6E05FEDC-347E-42A8-AE41-D268142CF408Q36775294-C205B56E-C81A-4A91-8702-11EFEA9CBB51Q37108643-DCDAA4FF-13BE-4776-9B43-4C7DD3A48448Q37350672-44FAAC8B-A3B7-4507-966E-3CA1117D1AA7Q37402134-80B80E32-5AF7-494D-91D5-C3990CAD1EADQ38166975-C829E056-3F7B-4195-9C51-2E9F6F3024A1Q44939911-00B7E9DC-1212-441C-AC4C-524037ACA94FQ48176913-CA142C3F-2181-4E60-B29B-30BC0F8D4A10Q51756583-BAC83977-2138-4E6C-9775-CCC6481E2D52Q52146902-6BF1FAC7-089F-4E44-93E9-B293E917E682
P2860
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@ast
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@en
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@nl
type
label
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@ast
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@en
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@nl
prefLabel
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@ast
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@en
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@nl
P2093
P2860
P50
P3181
P1433
P1476
[11C]flumazenil binding is inc ...... uced elevations in GABA levels
@en
P2093
Chester A Mathis
Chi-Min Chen
Michael Himes
N Scott Mason
Rajesh Narendran
Raymond Y Cho
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0032443
P407
P577
2012-02-27T00:00:00Z